Brief: Hls Therapeutics Provides Investor Update On The Canadian Launch Of Vascepa®
28/01/2020 11:38
Jan 28 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS PROVIDES INVESTOR UPDATE ON THE CANADIAN
LAUNCH
OF VASCEPA® (ICOSAPENT ETHYL)
* HLS THERAPEUTICS INC - VASCEPA TO BE AVAILABLE ON OR ABOUT
FEBRUARY 18, 2020, SUPPORTED BY A NATIONAL CARDIOVASCULAR
SALESFORCE
* HLS THERAPEUTICS INC - VASCEPA IS SUPPORTED BY DATA FROM
REDUCE-IT TRIAL
Source text for Eikon: ID:nCNWrTCvMa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group